1
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Food Effect and DDI of Ascending Doses of the MEK Inhibitor Zapnometinib
Condition(s):HealthyLast Updated:August 1, 2023Completed
Hide Studies Not Open or Pending
Condition(s):HealthyLast Updated:August 1, 2023Completed
Condition(s):COVID-19Last Updated:September 22, 2022Terminated
Condition(s):InfluenzaLast Updated:May 13, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.